Evidence map›Paper›PMID 28729697›Full record

ArticleScientific reports2017

Identification and structural characterization of LytU, a unique peptidoglycan endopeptidase from the lysostaphin family.

Vytas Raulinaitis, Helena Tossavainen, Olli Aitio, Jarmo T Juuti, Keiichi Hiramatsu, Vesa Kontinen, Perttu Permi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Biomolecular NMR assignments · 2023
    Article
  7. Structural and Functional Characterization of β-lytic Protease fromInternational journal of molecular sciences · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Structural Characterization of EnpA D,L-Endopeptidase fromInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Article
  16. Enzyme-Functionalized Mesoporous Silica Nanoparticles to TargetInternational journal of nanomedicine · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Vytas RaulinaitisProgram in Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Viikinkaari 1, P.O. Box 65, FI-00014, Helsinki, Finland.
Helena TossavainenProgram in Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Viikinkaari 1, P.O. Box 65, FI-00014, Helsinki, Finland.
Olli AitioProgram in Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Viikinkaari 1, P.O. Box 65, FI-00014, Helsinki, Finland.
Jarmo T JuutiAntimicrobial Resistance Unit, Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, P.O. Box 30, FI-00271, Helsinki, Finland.
Keiichi HiramatsuResearch Centre for Infection Control Science, Juntendo University, Bunkyo-ku, Tokyo, Japan.
Vesa KontinenAntimicrobial Resistance Unit, Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, P.O. Box 30, FI-00271, Helsinki, Finland.
Perttu PermiProgram in Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Viikinkaari 1, P.O. Box 65, FI-00014, Helsinki, Finland. perttu.permi@jyu.fi.
University of Helsinki · FIJuntendo University · JPFinnish Institute for Health and Welfare · FIUniversity of Jyväskylä · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We introduce LytU, a short member of the lysostaphin family of zinc-dependent pentaglycine endopeptidases. It is a potential antimicrobial agent for S. aureus infections and its gene transcription is highly upregulated upon antibiotic treatments along with other genes involved in cell wall synthesis. We found this enzyme to be responsible for the opening of the cell wall peptidoglycan layer during cell divisions in S. aureus. LytU is anchored in the plasma membrane with the active part residing in the periplasmic space. It has a unique Ile/Lys insertion at position 151 that resides in the catalytic site-neighbouring loop and is vital for the enzymatic activity but not affecting the overall structure common to the lysostaphin family. Purified LytU lyses S. aureus cells and cleaves pentaglycine, a reaction conveniently monitored by NMR spectroscopy. Substituting the cofactor zinc ion with a copper or cobalt ion remarkably increases the rate of pentaglycine cleavage. NMR and isothermal titration calorimetry further reveal that, uniquely for its family, LytU is able to bind a second zinc ion which is coordinated by catalytic histidines and is therefore inhibitory. The pH-dependence and high affinity of binding carry further physiological implications.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsBinding SitesCatalytic DomainCell MembraneEndopeptidasesHydrogen-Ion ConcentrationLysostaphinMutationProtein BindingProtein Interaction Domains and MotifsProteolysisStaphylococcus aureusStructure-Activity RelationshipZincAnti-Bacterial AgentsEndopeptidasesLysostaphinpeptidoglycan endopeptidaseZinc

Identifiers

PMID28729697
PMCPMC5519744
OpenAlexW2735043999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.